glioblastoma

Taming tumor chaos: Researchers uncover key to improving glioblastoma treatment

by Brown University edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Graphical abstract. Credit: Cell Reports (2025). DOI: 10.1016/j.celrep.2025.116516 A study by Brown University Health researchers has identified a crucial factor that may help improve treatment for glioblastoma, one of the most aggressive and common forms of adult brain cancer. The findings, […]

Taming tumor chaos: Researchers uncover key to improving glioblastoma treatment Read More »

Insilico Medicine and Atossa Therapeutics publish AI-driven study in Nature’s Scientific Reports identifying (Z)-endoxifen as a potential therapeutic candidate for glioblastoma

Peer-Reviewed Publication InSilico Medicine image: Evaluation of (Z)-endoxifen as a potential therapy for glioblastoma multiforme through computational and experimental analyses view more   Credit: Insilico Medicine Cambridge, MA — 12/02/2025 — Insilico Medicine (“Insilico”), a global leader in AI-powered drug discovery, and Atossa Therapeutics (“Atossa”) (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel treatments for breast cancer

Insilico Medicine and Atossa Therapeutics publish AI-driven study in Nature’s Scientific Reports identifying (Z)-endoxifen as a potential therapeutic candidate for glioblastoma Read More »

Glioblastomas affect much more than just the brain, scientists discover

by Albert Einstein College of Medicine edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes A case of glioblastoma relapsed during immunotherapy. Credit: Yan Li et al, CC BY 4.0 Scientists at Montefiore Einstein Comprehensive Cancer Center (MECCC) and Albert Einstein College of Medicine have shown for the first time that glioblastoma—the deadliest form of brain cancer—affects not

Glioblastomas affect much more than just the brain, scientists discover Read More »

Research spotlight: Combination therapy shows promise for overcoming treatment resistance in glioblastoma

Researchers have identified a previously unknown determinant of resistance to immune checkpoint blockers in glioblastoma and a strategy to overcome it. Peer-Reviewed Publication Massachusetts General Hospital Rakesh Jain, PhD, director of the Edwin Steele Laboratories for Tumor Biology in the Department of Radiation Oncology at Massachusetts General Hospital and Andrew Werk Professor of Radiation Oncology at Harvard Medical School,

Research spotlight: Combination therapy shows promise for overcoming treatment resistance in glioblastoma Read More »

Fusion superkine and focused ultrasound could enable targeted, noninvasive therapy for glioblastoma

by ITER edited by Stephanie Baum, reviewed by Robert Egan   The fusion superkine (FSK) stimulated higher tumor regression and enhanced survival in vivo more than the individual superkine (IL-24S) or cytokine (IL-15) in glioblastoma cancer models. In addition, killing of GBM cells was induced, as well as increased tumor infiltration of T cells, dendritic cells (DCs), macrophages

Fusion superkine and focused ultrasound could enable targeted, noninvasive therapy for glioblastoma Read More »

Scroll to Top